Therapeutic efficacy and immunoregulatory effect of Qiangji Jianli Capsule for patients with myasthenia gravis: Study protocol for a series of randomized, controlled N-of-1 trials

INTRODUCTION: Myasthenia gravis (MG) is an autoimmune disease in which antibodies directly target components of the neuromuscular junction, causing neuromuscular conduction damage that leads to muscle weakness. The current pharmaceutical treatment for MG is still not ideal to address the problems of...

Descripción completa

Detalles Bibliográficos
Autores principales: Weng, Senhui, Fan, Zhixin, Qiu, Guoyu, Liu, Fengbin, Huang, Linwen, Li, Jinghao, Jiang, Xiaotao, Song, Zhixuan, Gao, Yuxia, Zhong, Zhuotai, He, Long, Kang, Liping, Wu, Yunlong, Chen, Benshu, Jiang, Qilong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
3700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7748195/
https://www.ncbi.nlm.nih.gov/pubmed/33371107
http://dx.doi.org/10.1097/MD.0000000000023679

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7748195/
https://www.ncbi.nlm.nih.gov/pubmed/33371107
http://dx.doi.org/10.1097/MD.0000000000023679

Ejemplares similares